Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06418893

Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.

Effect of Isoflurane and Target Control Infusion (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients: A Randomized Controlled Trial.

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Both isoflurane and propofol are being used to give anaesthesia for living donor liver transplant in our institute. Propofol when compared to isoflurane has advantages like early awakening from anaesthesia, reduced nausea, vomiting in the postoperative period. Propofol also has antioxidant properties. Because of its antioxidant properties propofol may have a protective effect against oxidative stress and ischemia reperfusion injury in major organs during liver transplant surgery. However, there are no studies showing the effect of isoflurane and propofol on Intraoperative hemodynamics and postoperative liver and kidney functions.Thus, we are conducting this study to know the effect of these agents on intraoperative hemodynamics and postoperative liver and kidney function.

Conditions

Interventions

TypeNameDescription
DRUGTarget control infusion propofoltarget control infusion of propofol for target plasma concentration 2.5mcg/ml and BIS 40-60
DRUGInhalational isofluraneInhalational Isoflurane at concentration 1-2%

Timeline

Start date
2023-08-01
Primary completion
2024-10-01
Completion
2024-10-31
First posted
2024-05-17
Last updated
2024-05-17

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06418893. Inclusion in this directory is not an endorsement.